Pancreatic Cancer Research

ResearcherUniversity of BernActive in the last 2 years

Ulf Kessler

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9547-9426; OpenAlex author ID A5020551439. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-026-02347-y↗
  2. Neoadjuvant Chemotherapy in Pancreatic Cancer: An Appraisal of the Current High-Level Evidence. Last author DOI 10.1159/000510343↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Steve Robatel · 1 shared paper, 2026 · strength 0.25
  2. Mirjam Schenk · 1 shared paper, 2026 · strength 0.25
  3. Max Nobis · 1 shared paper, 2026 · strength 0.25
  4. Martin Wartenberg · 1 shared paper, 2026 · strength 0.25
  5. Philip C. Müller · 1 shared paper, 2021 · strength 0.13
  6. Thilo Hackert · 1 shared paper, 2021 · strength 0.13
  7. Michael C. Frey · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.